About Proveca
Proveca is a company based in Manchester (United Kingdom) founded in 2010.. Proveca has raised $8.45 million across 2 funding rounds from investors including Kreos Capital, Albion Capital and Catapult Ventures. The company has 23 employees as of July 31, 2022. Proveca offers products and services including Paediatric Medicines. Proveca operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Manchester, United Kingdom
- Employees 23 as on 31 Jul, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Proveca Limited
- Date of Incorporation 15 Jul, 2010
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.45 M (USD)
in 2 rounds
-
Latest Funding Round
$5.02 M (USD), Series A
Mar 29, 2017
-
Investors
Kreos Capital
& 2 more
-
Employee Count
23
as on Jul 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proveca
Proveca offers a comprehensive portfolio of products and services, including Paediatric Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for children's neurological and cardiac conditions.
Unlock access to complete
Funding Insights of Proveca
Proveca has successfully raised a total of $8.45M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.02 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.0M
-
First Round
First Round
(01 Jan 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Series A - Proveca | Valuation | Catapult Ventures | |
| Jan, 2013 | Amount | Series A - Proveca | Valuation | Albion Capital Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Proveca
Proveca has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Kreos Capital, Albion Capital and Catapult Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location | |
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed by Albion Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Proveca
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Proveca
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proveca Comparisons
Competitors of Proveca
Proveca operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proveca
Frequently Asked Questions about Proveca
When was Proveca founded?
Proveca was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Proveca located?
Proveca is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Is Proveca a funded company?
Proveca is a funded company, having raised a total of $8.45M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.43M, raised on Jan 01, 2013.
How many employees does Proveca have?
As of Jul 31, 2022, the latest employee count at Proveca is 23.
What does Proveca do?
Proveca was founded in 2010 in Manchester, United Kingdom, within the pharmaceutical sector focused on pediatric care. Medicines targeting chronic conditions such as Cerebral Palsy, Epilepsy, and Heart Failure in children are developed and commercialized. A facility for licensing off-patent medicines tailored for pediatric use is also operated, supporting therapy access in these areas.
Who are the top competitors of Proveca?
Proveca's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.
What products or services does Proveca offer?
Proveca offers Paediatric Medicines.
Who are Proveca's investors?
Proveca has 3 investors. Key investors include Kreos Capital, Albion Capital, and Catapult Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.